Onaiza Cadoret-Manier - 15 Jun 2023 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role: Director
Signature: /s/ Christopher Krueger, as Attorney-in-Fact
Issuer symbol: VTYX
Transactions as of: 15 Jun 2023
Net transactions value: $0
Form type: 4
Filing time: 16 Jun 2023, 21:10:59 UTC
Previous filing: 19 Apr 2023
Next filing: 04 Jan 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VTYX	Stock Option (right to buy)	Award	$0	+15,937		$0.000000	15,937	15 Jun 2023	Common Stock	15,937	$34.83	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the Vesting Commencement Date (as defined below) or, (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date the option was granted, in each case, subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the applicable vesting date. The "Vesting Commencement Date" shall mean June 7, 2023.

Content

The shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the Vesting Commencement Date (as defined below) or, (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date the option was granted, in each case, subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the applicable vesting date. The "Vesting Commencement Date" shall mean June 7, 2023.